Value-based management, EVA and stock price performance in Canada

被引:17
|
作者
Athanassakos, George [1 ]
机构
[1] Univ Western Ontario, Richard Ivey Sch Business, London, ON, Canada
关键词
economic value added; stock prices; surveys;
D O I
10.1108/00251740710828663
中图分类号
F [经济];
学科分类号
02 ;
摘要
Purpose - The purpose of this paper is to determine the extent to which Canadian companies have embraced value-based management (VBM) methods, identify the characteristics of these companies and of the executives responsible for the introduction of VBM in their organisations and assess the stock price performance of the companies that use VMB vs. those that do not. Design/methodology/approach - The study is based on a survey of CEOs of a large sample of Canadian companies and examines the relation of a number of explanatory variables, including stock price performance, to the probability of using VBM versus not using VBM via a regression analysis of qualitative choice, namely logit analysis. Findings - The study finds that value-based management methods are widely used in Canada, with the likelihood of usage being higher for larger companies with younger and more educated executives with an accounting/finance background. The statistical analysis that follows the tabulation of survey results indicates companies that used EVA had a better stock price performance than those not using EVA. Moreover, our logit regression analysis shows that companies with better stock market performance exhibited higher likelihood of using EVA. Practical implications - The study implies that the lower usage of EVA in Canada, especially at the corporate level, provides some explanation for the stock market under-performance of the Canada market vis-a-vis the USA in the 1990s. Originality/value - To our knowledge, this study serves as the first widespread evaluation of VBM methods in Canada and their effect on company and stock price performance.
引用
收藏
页码:1397 / 1411
页数:15
相关论文
共 50 条
  • [31] VALUE-BASED PRICE FORECASTING: AN ACCURATE METHOD FOR ORPHAN DRUGS?
    Anstee, K.
    Jao, R.
    VALUE IN HEALTH, 2023, 26 (06) : S266 - S267
  • [32] Value-based performance and risk management in supply chains: A robust optimization approach
    Hahn, G. J.
    Kuhn, H.
    INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS, 2012, 139 (01) : 135 - 144
  • [33] Value-Based Insurance Design: More Health at Any Price
    Fendrick, A. Mark
    Martin, Jenifer J.
    Weiss, Alison E.
    HEALTH SERVICES RESEARCH, 2012, 47 (01) : 404 - 413
  • [34] EVA (R) and Stock Performance
    Griffith, John M.
    JOURNAL OF INVESTING, 2006, 15 (02): : 75 - 78
  • [35] APPLYING A VALUE-BASED PRICE ACROSS DIFFERENT DISEASE AREAS
    Wilson, T.
    Kusel, J.
    Brooks-Rooney, C.
    Costello, S.
    VALUE IN HEALTH, 2012, 15 (07) : A285 - A285
  • [36] Value-based leadership and human-based management
    Wu, WK
    Liu, Y
    MANAGEMENT SCIENCES AND GLOBAL STRATEGIES IN THE 21ST CENTURY, VOLS 1 AND 2, 2004, : 1882 - 1887
  • [37] ALIGNING BUSINESS PLANNING TO VALUE-BASED MANAGEMENT
    Britzelmaier, Bernd
    Huss, Christoph
    EUROPEAN AND MEDITERRANEAN TRENDS AND CHALLENGES IN THE 21ST CENTURY, 2008, : 135 - 146
  • [38] South Korean Chaebols and Value-Based Management
    Moskalev, Sviatoslav
    Park, Seung Chan
    JOURNAL OF BUSINESS ETHICS, 2010, 92 (01) : 49 - 62
  • [39] Value-Based Management in Biosciences Research and Development
    Eapen, Gill
    JOURNAL OF APPLIED CORPORATE FINANCE, 2005, 17 (02) : 105 - +
  • [40] COPD Management in a Value-Based Healthcare System
    Vogenberg, F. Randy
    Tinkelman, David
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (04): : 195 - +